B. Braun Announces Approval and Commercialization of First Generic Sugammadex Injection in the U.S. Market
B. Braun Announces Approval and Commercialization of First Generic Sugammadex Injection in the U.S. Market
B. Braun
Private
Infusion therapy and pain management
Company Info
Recent News
Leadership Team
To be confirmed
Chief Executive Officer
To be confirmed
Chief Medical Officer
To be confirmed
Chief Scientific Officer